Plasma catecholamine metabolites are associated with disease activity and pathophysiological features in systemic lupus erythematosus using targeted LC–MS/MS
Open Access
- 29 December 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Systemic lupus erythematosus (SLE) presents diagnostic and disease monitoring challenges due to its heterogeneity and variable activity. In this cross-sectional study, we investigated the association of plasma catecholamine (CA) metabolites with SLE status and disease activity. Plasma samples from 88 SLE patients and 64 healthy controls were analyzed using targeted liquid chromatography-tandem mass spectrometry to quantify dopamine (DA), epinephrine (E), norepinephrine (NE), 3-methoxytyramine (3MT), metanephrine (MN), and normetanephrine (NMN). Significant alterations in CA metabolites levels were observed in SLE patients compared to controls, independent of glucocorticoid treatment. Orthogonal partial least squares-discriminant analysis (OPLS-DA) suggested distinct metabolic profiles in active SLE. NE, NMN, MN, and E showed notable group differences and correlations with inflammatory markers, clinical features, complement levels, and SLE Disease Activity Index (SLEDAI) scores. Receiver operating characteristic analysis demonstrated strong diagnostic performance for individual CA biomarkers, while combined plasma CA metabolites assessment yielded superior predictive capability for SLE activity (AUC: 0.866, 95% CI: 0.785–0.947). These findings highlight the potential of plasma CA metabolites, particularly NE and NMN, are associated with SLE disease activity and may serve as potential associative biomarkers. Further validation in independent and longitudinal cohorts is warranted.Keywords
Funding Information
- The National Natural Science Foundation of China (82502192)
- The National Natural Science Foundation of China (82302586)
- The Youth Science Foundation of Xiangya Hospital (2024Q17)
- the Hunan Health Commission Research Project (20256933)
- Graduate Research and Innovation Project of Central South University (No. 2022ZZTS0886)
- the Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University
This publication has 68 references indexed in Scilit:
- Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysisRheumatology International, 2022
- Immunological pathogenesis and treatment of systemic lupus erythematosusWorld Journal of Pediatrics, 2019
- Brief Report: Lupus—An Unrecognized Leading Cause of Death in Young Females: A Population‐Based Study Using Nationwide Death Certificates, 2000–2015Arthritis & Rheumatology, 2018
- Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?Journal of Neuroimmune Pharmacology, 2012
- An opposing time‐dependent immune‐modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen–induced arthritisArthritis & Rheumatism, 2005
- Epinephrine producing pheochromocytoma. Is the secretory pattern decisive for the clinical manifestation?Journal of Endocrinological Investigation, 2004
- Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody testsArthritis Care & Research, 2002
- The syntax of immune-neuroendocrine communicationImmunology Today, 1994
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Induction of tyrosine hydroxylase synthesis in rat superior cervical ganglia in vitro by nerve growth factor and dexamethasoneBiochemical and Biophysical Research Communications, 1977